Monomethyl auristatin E (MMAE) Monoclonal Antibody

Cat.#: 176727

Size:

Special Price 322.6 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Monomethyl auristatin E (MMAE) Monoclonal Antibody
  • Documents
  • Description
    Product has been tested in direct ELISA.
  • Tested applications
    ELISA
  • Species reactivity
    Chemical
  • Isotype
    Mouse IgG1, κ
  • Preparation
    MMAE conjugated with KLH. Protein G affinity purified
  • Clonality
    Monoclonal
  • Formulation
    PBS(pH7.4), lyophilized. Reconstitution: Adding sterile water, prepare a stock solution of 2.0 mg/ml.
  • Storage instructions
    Store at -20℃. Avoid freeze / thaw cycles.
  • Applications
    ELISA: 1:5,000-1:20,000
  • Validations

    ELISA Binding Assay of Anti-MMAE Antibody to different proteins.

    ELISA Binding Assay of Anti-MMAE Antibody to different proteins.

    ELISA analysis of Anti-MMAE Monoclonal Antibody with MMAE-BSA, MMAE ADC and BSA. Anti-MMAE Monoclonal Antibody can bind to MMAE-BSA or MMAE ADC but not carrier protein.

    ELISA Binding Assay of Anti-MMAE Antibody

    ELISA Binding Assay of Anti-MMAE Antibody

    Immobilized MMAE ADC at 2μg/mL (100μL/well) can bind anti-MMAE mouse monoclonal antibody.

  • Background
    Auristatins are synthetic analogs of dolastatin 10 (D10), a highly cytotoxic antineoplastic agent employed for cancer chemotherapy, which is derived from a marine species known as Dolabella auricularia. Monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF) are identified as the best analogs of dolastatin 10, which bind to microtubules and prevent cell proliferation by inhibiting mitosis. MMAE is one of the most commonly used payloads for developing antibody–drug conjugates (ADC).
  • References
    • Okeley NM, Miyamoto JB, Zhang X, Sanderson RJ, Benjamin DR, Sievers EL, Senter PD, Alley SC. Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate. Clin Cancer Res. 2010 Feb 1;16(3):888-97. doi: 10.1158/1078-0432.CCR-09-2069. Epub 2010 Jan 19. Erratum in: Clin Cancer Res. 2011 Aug 15;17(16):5524. PMID: 20086002.
    • Buckel L, Savariar EN, Crisp JL, Jones KA, Hicks AM, Scanderbeg DJ, Nguyen QT, Sicklick JK, Lowy AM, Tsien RY, Advani SJ. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-1387. doi: 10.1158/0008-5472.CAN-14-1931. Epub 2015 Feb 13. PMID: 25681274; PMCID: PMC4458508.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"